Behavioral therapy improved continence after prostatectomy

Behavioral therapy helped reduce urinary incontinence in men who had the condition for at least 1 year following radical prostatectomy.

In a prospective randomized trial, 208 men aged 51 to 84 years whose incontinence persisted for 1 to 17 years after radical prostatectomy were assigned to 1 of 3 groups: One set of men underwent 8 weeks of behavioral therapy (four visits approximately 2 weeks apart), which entailed pelvic-floor-muscle training and bladder-control strategies. The men in the “behavior plus” group received the behavioral therapy as well as in-office, dual-channel electromyography biofeedback and daily home pelvic-floor electrical stimulation at 20 Hz, current up to 100 mA. Finally, the control group members kept daily bladder diaries that were reviewed during their clinic visits—every 2 weeks for 8 weeks.

At the end of 8 weeks, mean incontinence episodes had fallen by 55% in the behavioral therapy group, from 28 to 13 per week. The behavior-plus intervention yielded a 51% decrease, from 26 to 12 episodes per week. Both reductions were significantly greater than the 24% drop noted in the control group (from 24 to 21 incontinence episodes per week). At the end of treatment, complete continence was reported by 15.7% of the men undergoing behavior therapy and 17.1% of the behavior-plus group, but just 5.0% of the control group.

The active-treatment improvements endured through the1-year follow-up period: The behavior group participants ended follow-up with a 50% reduction in episodes, to 13.5 episodes per week, and the behavior-plus men averaged a 59% reduction, to 9.1 episodes per week (JAMA. 2011;305:151-159).

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs